Targeting oxidative stress attenuates trinitrobenzene sulphonic acid induced inflammatory bowel disease like symptoms in rats: Role of quercetin

Indian Journal of Pharmacology

Volumn 46, Issue 3, 2014, Pages 286-291

  Dodda, Dilip ^a,b   Chhajed, Ruchi ^c   Mishra, Jitendriya ^d,e   Padhy, Monalisa ^d  

^a KAKATIYA UNIVERSITY   (India)

^b Vaagdevi College of Pharmacy   (India)

^c NMT Gujarati College of Pharmacy   (India)

^d Roland Institute of Pharmaceutical Sciences   (India)

^e PANJAB UNIVERSITY   (India)

Author keywords

Inflammatory bowel disease; Myeloperoxidase; Oxidative stress; Ulcer index

Indexed keywords

GLUTATHIONE; MYELOPEROXIDASE; NITRITE; QUERCETIN; SALAZOSULFAPYRIDINE; TRINITROBENZENESULFONIC ACID; ANTIOXIDANT; NITRIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; COLITIS; COLON ULCER; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; ENZYME ACTIVITY; FECES; INFLAMMATORY BOWEL DISEASE; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; RECTUM HEMORRHAGE; SYMPTOM; WISTAR RAT; ANIMAL; BLOOD; CHEMICALLY INDUCED; COLON; DRUG EFFECTS; INFLAMMATORY BOWEL DISEASES; METABOLISM; PATHOLOGY;

ANIMALS; ANTIOXIDANTS; COLON; GLUTATHIONE; INFLAMMATORY BOWEL DISEASES; LIPID PEROXIDATION; MALE; NITRATES; NITRITES; OXIDATIVE STRESS; QUERCETIN; RATS, WISTAR; TRINITROBENZENESULFONIC ACID;

EID: 84901404034     PISSN: 02537613     EISSN: 19983751     Source Type: Journal    
DOI: 10.4103/0253-7613.132160     Document Type: Article

References (25)

1. Fiocchi C. Inflammatory bowel disease: Etiology and pathogenesis. Gastroenterology 1998;115:182-205.
2. Simmonds NJ, Rampton DS. Inflammatory bowel disease - A radical view. Gut 1993;34:865-8.
3. Lih-Brody L, Powell SR, Collier KP, Reddy GM, Cerchia R, Kahn E, et al. Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease. Dig Dis Sci 1996;41:2078-86.
4. Nielsen OH, Ahnfelt-Rønne I. Involvement of oxygen-derived free radicals in the pathogenesis of chronic inflammatory bowel disease. Klin Wochenschr 1991;69:995-1000.
5. Barbosa DS, Cecchini R, El Kadri MZ, Rodríguez MA, Burini RC, Dichi I. Decreased oxidative stress in patients with ulcerative colitis supplemented with fish oil omega-3 fatty acids. Nutrition 2003;19:837-42.
6. Elson CO, Sartor RB, Tennyson GS, Riddell RH. Experimental models of inflammatory bowel disease. Gastroenterology 1995;109:1344-67.
7. Kelly GS. Quercetin. Monograph. Altern Med Rev 2011;16:172-94.
8. Wirtz S, Neufert C, Weigmann B, Neurath MF. Chemically induced mouse models of intestinal inflammation. Nat Protoc 2007;2:541-6.
9. Mithun VK, Amit DK, Sucheta DB. Anti-inflammatory effect of Daucus carota root on experimental colitis in rats. Int J Pharm Pharm Sci 2012;4:337-43.
10. Ganguly AK. A method for quantitative assessment of experimentally produced ulcers in the stomach of albino rats. Experientia 1969;25:1224.
11. Millar AD, Rampton DS, Chander CL, Claxson AW, Blades S, Coumbe A, et al. Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis. Gut 1996;39:407-15.
12. Krawisz JE, Sharon P, Stenson WF. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 1984;87:1344-50.
13. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-75.
14. Moron MS, Depierre JW, Mannervik B. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta 1979;582:67-78.
15. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351-8.
16. Miranda KM, Espey MG, Wink DA. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 2001;5:62-71.
17. Woodruff TM, Arumugam TV, Shiels IA, Newman ML, Ross PA, Reid RC, et al. A potent and selective inhibitor of group IIa secretory phospholipase A2 protects rats from TNBS-induce colitis. Int Immunopharmacol 2005;5:883-92.
18. MacPherson BR, Pfeiffer CJ. Experimental production of diffuse colitis in rats. Digestion 1978;17:135-50.
19. Babbs CF. Oxygen radicals in ulcerative colitis. Free Radic Biol Med 1992;13:169-81.
20. McKenzie SJ, Baker MS, Buffinton GD, Doe WF. Evidence of oxidant-induced injury to epithelial cells during inflammatory bowel disease. J Clin Invest 1996;98:136-41.
21. Liu X, Wang J. Anti-inflammatory effects of iridoid glycosides fraction of Folium syringae leaves on TNBS-induced colitis in rats. J Ethnopharmacol 2011;133:780-7.
22. Krawisz JE, Sharon P, Stenson WF. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 1984;87:1344-50.
23. Sies H. Glutathione and its role in cellular functions. Free Radic Biol Med 1999;27:916-21.
24. Budarf ML, Labbé C, David G, Rioux JD. GWA studies: Rewriting the story of IBD. Trends Genet 2009;25:137-46.
25. Lee JY, Kang HS, Park BE, Moon HJ, Sim SS, Kim CJ. Inhibitory effects of Geijigajakyak-Tang on trinitrobenzene sulfonic acid-induced colitis. J Ethnopharmacol 2009;126:244-51.